Nectar Lifesciences Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

22.43

22.43

22.43

22.43

22.43

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

1,042.17

1,064.44

1,038.31

1,112.18

1,082.21

Loan funds

Secured loans

753.83

859.93

840.24

741.20

780.04

Unsecured loans

-

-

-

-

21.52

Total

1,818.42

1,946.79

1,900.97

1,875.80

1,906.20

Uses of funds

Fixed assets

Gross block

1,425.16

1,439.15

1,439.80

1,404.86

1,399.79

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

763.18

716.06

667.91

620.01

574.98

Net block

661.97

723.10

771.89

784.85

824.82

Capital work-in-progress

77.78

85.10

98.63

115.00

99.55

Investments

0.56

1.03

1.03

0.74

1.11

Net current assets

Current assets, loans & advances

1,448.90

1,580.48

1,598.65

1,731.58

1,778.30

Less : current liabilities & provisions

370.79

442.92

569.22

756.37

797.58

Total net current assets

1,078.11

1,137.56

1,029.43

975.22

980.72

Miscellaneous expenses not written

-

-

-

-

-

Total

1,818.42

1,946.79

1,900.97

1,875.80

1,906.20

Notes:

Book value of unquoted investments

0.25

0.58

0.58

0.58

0.60

Market value of quoted investments

0.31

0.56

0.50

0.17

0.65

Contingent liabilities

164.80

76.77

93.25

75.71

53.17

Number of equity sharesoutstanding (Lacs)

2242.61

2242.61

2242.61

2242.61

2242.61